Board Member
Biomarin Pharmaceutical Inc (BMRN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Alexander Hardy is recorded as CEO and Board Member at Biomarin Pharmaceutical Inc (BMRN). Biomarin Pharmaceutical Inc reported in an 8-K filed November 3, 2023 that Alexander Hardy was appointed member of the Board, effective December 1, 2023. Biomarin Pharmaceutical Inc reported in an 8-K filed November 3, 2023 that Alexander Hardy was appointed President and Chief Executive Officer, effective December 1, 2023. The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $21,927,563 for Alexander Hardy in fiscal 2025, including a base salary of $1,130,769. Disclosed compensation is on record for 3 fiscal years. Alexander Hardy has spoken on 11 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on August 6, 2026.
“On November 1, 2023, the Company announced the appointment of Alexander Hardy, age 55, to serve as the Company's President and Chief Executive Officer and as a member of the Board, effective as of December 1, 2023 (the "Effective Date").”
“On November 1, 2023, the Company announced the appointment of Alexander Hardy, age 55, to serve as the Company's President and Chief Executive Officer and as a member of the Board, effective as of December 1, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-12-01–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2023-12-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biomarin Pharmaceutical Inc (BMRN) | President and CEO | $1,130,769 | $21,927,563 |
| 2024 | Biomarin Pharmaceutical Inc (BMRN) | President and CEO — | $1,050,000 | $14,853,605 |
| 2023 | Biomarin Pharmaceutical Inc (BMRN) | President and CEO — | $64,615 | $17,875,236 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
